Close Menu

Diagnostics Business News

Financial news, mergers and acquisitions, partnerships, and alliances.

Takeda said that the tool evaluates risk for developing complications associated with Crohn's disease and helps support personalized clinical decision-making.

Tempus said that Akesogen's lab provides a range of testing services, including for inherited risk of cancer, microbiome profiling, whole-genome genotyping, and more.

The firm said it is turbocharging the lateral flow format with sensitivity and cost suitable for over-the-counter STI testing.

The firm said that in its product pipeline in 2019 it focused on organ transplant and lung health, involving use of its multiplexed research-use TORdx Lung tests.

Pressure associated with competition and reimbursement may erode GenMark's market share and product pricing, JP Morgan said.